Metabolic Effects of the SGLT2 Inhibitor Dapagliflozin in Heart Failure Across the Spectrum of Ejection Fraction

  • Senthil Selvaraj
  • , Shachi Patel
  • , Andrew J. Sauer
  • , Robert W. Mcgarrah
  • , Philip Jones
  • , Lydia Coulter Kwee
  • , Sheryl L. Windsor
  • , Olga Ilkayeva
  • , Michael J. Muehlbauer
  • , Christopher B. Newgard
  • , Barry A. Borlaug
  • , Dalane W. Kitzman
  • , Sanjiv J. Shah
  • , Kenneth B. Margulies
  • , Mansoor Husain
  • , Silvio E. Inzucchi
  • , Darren K. Mcguire
  • , David E. Lanfear
  • , Ali Javaheri
  • , Guillermo Umpierrez
    • Robert J. Mentz, Kavita Sharma, Mikhail N. Kosiborod, Svati H. Shah

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Metabolic Effects of the SGLT2 Inhibitor Dapagliflozin in Heart Failure Across the Spectrum of Ejection Fraction'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science